Codman Neuro
- Company typePrivate
- Founded2001
- HeadquartersRaynham, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Codman Neuro firmographics
Firmographics- Name
- Codman Neuro
- Legal name
- Codman & Shurtleff
- Website
- https://codman.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Where Codman Neuro is headquartered
LocationHeadquarters
- HQ city
- Raynham
- HQ country
- United States
- HQ region
- North America
Markets served
Codman Neuro business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
Codman Neuro product offering
Product offeringCore offering
Codman Neuro manufactures and sells specialty neurosurgery and neurovascular medical devices for hospitals and neurosurgical centers. Its core offerings include intracranial pressure (ICP) monitoring devices used in neurocritical care, hydrocephalus shunt valves and catheters, external cerebrospinal fluid (CSF) drainage systems, and complementary neurosurgical products such as dural repair grafts, CUSA tissue ablation, cranial reconstruction and stabilization, and electrosurgery devices. The company sells these products to neuro-ICUs, neurosurgery departments, and critical care units worldwide.
Product overview
Codman Neuro products include intracranial pressure monitoring devices for neurocritical care applications. Based on market research data, Codman & Shurtleff is identified as a key player in the global intracranial pressure monitoring devices market, which was valued at USD 1.89 billion in 2025 and projected to reach USD 3.71 billion by 2035.
Differentiator
Problem solved
Functional benefit
Products and services
- Codman & Shurtleff Intracranial Pressure Monitoring Devices
Companies that use Codman Neuro
Customer profileSegments1 record
Ideal customer profiles1 record
Codman Neuro technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Codman Neuro partnerships and signals
Strategic signalScale indicators2 records
Recent moves3 records
Expansion highlights3 records
Codman Neuro competitors and assessment
Company assessmentMarket position
Weaknesses4 records
Competitive moat4 records
Customer concentration
Codman Neuro social profiles
Digital presenceCodman Neuro financial estimates
Financial estimateRevenue estimate
Valuation estimate
Codman Neuro leadership team
Management profileNumber of profiles
Profiles1 record
Codman Neuro funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Codman Neuro M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Codman Neuro
What does Codman Neuro do?
Codman Neuro manufactures and sells specialty neurosurgery and neurovascular medical devices for hospitals and neurosurgical centers. Its core offerings include intracranial pressure (ICP) monitoring devices used in neurocritical care, hydrocephalus shunt valves and catheters, external cerebrospinal fluid (CSF) drainage systems, and complementary neurosurgical products such as dural repair grafts, CUSA tissue ablation, cranial reconstruction and stabilization, and electrosurgery devices. The company sells these products to neuro-ICUs, neurosurgery departments, and critical care units worldwide.
When was Codman Neuro founded?
Codman Neuro was founded in 2001. It employs 1,001 to 5,000 people.
Where is Codman Neuro based?
Codman Neuro is headquartered in Raynham, United States, in the North America region.
Does Codman Neuro have an API?
No public API is recorded for Codman Neuro.